Atea Pharmaceuticals(AVIR) - 2024 Q4 - Earnings Call Transcript

Atea Pharmaceuticals (AVIR) Q4 2024 Earnings Call March 07, 2025 12:15 AM ET Company Participants Jonae Barnes - Senior Vice President of Investor Relations & Corporate CommunicationsJean-Pierre Sommadossi - Founder, Chairman, CEO & PresidentJanet Hammond - Chief Development OfficerArantxa Horga - Chief Medical OfficerAndrea Corcoran - CFO, Executive VP of Legal & Secretary Conference Call Participants Isabella Camaj - Equity Research AnalystAndy Hsieh - Research Analyst Operator Good afternoon, everybody, ...